Dashboard
Manage Tickers

MNMD


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

psychedelic-drugs-market-set-to-grow-by-137b-by-2028-driven-by-mental-health-disorders-and-ai-integration
Psychedelic Drugs Market Set To Grow By $1...
09/05/2024 16:53:46

The global psychedelic drugs market is projected to grow by USD 1.37 billion by 2028, driven by mental health needs and AI adva...

hc-wainwright--co-maintains-buy-on-mind-medicine-raises-price-target-to-55
HC Wainwright & Co. Maintains Buy on Mind ...
08/29/2024 12:02:55

HC Wainwright & Co. analyst Patrick Trucchio maintains Mind Medicine (NASDAQ:MNMD) with a Buy and raises the price targe...

mind-medicine-q2-2024-gaap-eps-026-beats-033-estimate-with-a-cash-balance-of-2431m-and-recently-closed-public-offering-of-75m-in-gross-proceeds-is-expected-to-provide-cash-runway-into-the-first-half-of-2026
Mind Medicine Q2 2024 GAAP EPS $(0.26) Bea...
08/13/2024 11:07:39

psychedelics-company-mindmed-prices-public-offering-aiming-to-raise-75m
Psychedelics Company MindMed Prices Public...
08/12/2024 16:14:59

mindmed-prices-public-offering-of-929m-common-shares-at-700-per-share-and-143m-pre-funded-warrants-at-6999-per-warrant
MindMed Prices Public Offering Of 9.29M Co...
08/09/2024 12:45:18

Expects Gross Proceeds Of Approximately $75M To Fund R&D And General Corporate Purposes

mind-medicine-mindmed-inc-announces-proposed-public-offering-to-fund-the-research-and-development-of-its-product-candidates-terms-undisclosed
Mind Medicine (MindMed) Inc. Announces Pro...
08/09/2024 10:04:09

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) (the "Company" or "MindMed"), a clinical stage biopharmaceutical com...

hc-wainwright--co-reiterates-buy-on-mind-medicine-maintains-35-price-target
HC Wainwright & Co. Reiterates Buy on Mind...
07/31/2024 12:11:05

HC Wainwright & Co. analyst Patrick Trucchio reiterates Mind Medicine (NASDAQ:MNMD) with a Buy and maintains $35 price t...

roth-mkm-maintains-buy-on-mind-medicine-maintains-36-price-target
Roth MKM Maintains Buy on Mind Medicine, M...
07/24/2024 15:21:47

Roth MKM analyst Jason Wittes maintains Mind Medicine (NASDAQ:MNMD) with a Buy and maintains $36 price target.

mindmed-announces-patent-covering-mm120-orally-disintegrating-tablet
MindMed Announces PAtent Covering MM120 Or...
07/17/2024 11:04:28

Core News & Articles
'MDMA Therapy Gets Support From Prominent ...
07/16/2024 18:51:34

https://www.greenmarketreport.com/mdma-therapy-gets-support-from-prominent-research-group-as-fda-weighs-action/ The paper noted...

Core News & Articles
'California Legislature Approves Bill To B...
07/08/2024 16:55:17

https://www.marijuanamoment.net/california-legislature-approves-bill-to-break-psychedelics-research-logjam-sending-it-to-governor/

mindmed-to-be-included-in-russell-2000-and-russell-3000-indexes-effective-today
MindMed To Be Included In Russell 2000 And...
06/28/2024 11:13:54

groundbreaking-fentanyl-vaccine-being-developed-to-prevent-fatal-overdoses-startup-secures-10m
Groundbreaking Fentanyl Vaccine Being Deve...
06/26/2024 22:58:07

The initiative focuses on commercializing academic research aimed at preventing deadly fentanyl from reaching the brain.

cantor-fitzgerald-reiterates-overweight-on-mind-medicine
Cantor Fitzgerald Reiterates Overweight on...
06/21/2024 16:31:46

Cantor Fitzgerald analyst Charles Duncan reiterates Mind Medicine (NASDAQ:MNMD) with a Overweight.

mindmed-reports-completion-of-end-of-phase-2-meeting-with-fda-says-reached-alignment-on-phase-3-development-strategy-for-mm120-in-generalized-anxiety-disorder
MindMed Reports Completion Of End-of-phase...
06/20/2024 11:13:34

Rob Barrow, Chief Executive Officer of MindMed, said, "This marks a significant milestone for MindMed and for the millions ...

Core News & Articles
'Oregon's First-In-Nation Psilocybin Indus...
06/12/2024 18:07:09

https://www.marijuanamoment.net/oregons-first-in-nation-psilocybin-industry-is-struggling-to-find-paying-customers-a-year-after...

psychedelic-stocks-trip-up-after-fda-advisors-reject-mdma-for-ptsd-treatment
Psychedelic Stocks Trip Up After FDA Advis...
06/05/2024 19:26:42

FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit,...

why-lands-end-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Lands' End Shares Are Trading Lower? H...
06/05/2024 17:04:26

whats-going-on-with-mindmed-and-psychedelic-stocks
What's Going On With MindMed And Psychedel...
06/05/2024 14:58:55

Mind Medicine (MindMed) shares are trading lower Wednesday after a Food and Drug Administration (FDA) panel rejected the approv...

rbc-capital-reiterates-outperform-on-mind-medicine-maintains-22-price-target
RBC Capital Reiterates Outperform on Mind ...
06/05/2024 14:47:20

RBC Capital analyst Brian Abrahams reiterates Mind Medicine (NASDAQ:MNMD) with a Outperform and maintains $22 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION